|
Q |
Colcr1 |
Colorectal carcinoma resistance QTL 1 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 4:8,428,551...30,449,094
|
|
Q |
Colcr2 |
Colorectal carcinoma resistance QTL 2 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr15:2,315,759...47,315,759
|
|
Q |
Colcr3 |
Colorectal carcinoma resistance QTL 3 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr18:1...25,022,372
|
|
Q |
Colcr4 |
Colorectal carcinoma resistance QTL4 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 6:30,937,632...75,937,632
|
|
Q |
Colcr5 |
Colorectal carcinoma resistance QTL 5 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 6:98,944,780...143,944,780
|
|
Q |
Colcr6 |
Colorectal carcinoma resistance QTL 6 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr15:83,700,787...108,192,169
|
|
Q |
Colcr7 |
Colorectal carcinoma resistance QTL 7 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr17:2,120,843...22,087,569
|
|
Q |
Colcr8 |
Colorectal carcinoma resistance QTL 8 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr18:31,990,891...76,990,891
|
|
Q |
Colcr9 |
Colorectal carcinoma resistance QTL 9 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr20:1...33,724,594
|
|
Q |
Colcs1 |
Colorectal carcinoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 5:160,071,170...172,129,029
|
|
|
Q |
Hcar1 |
Hepatocarcinoma resistance QTL 1 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr10:6,661,118...35,509,383
|
|
Q |
Hcar10 |
Hepatocarcinoma resistance QTL 10 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 8:49,610,204...68,373,388
|
|
Q |
Hcar11 |
Hepatocarcinoma resistance QTL 11 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 6:46,050,607...116,278,722
|
|
Q |
Hcar12 |
Hepatocarcinoma resistance QTL 12 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 3:49,872,657...138,829,559
|
|
Q |
Hcar13 |
Hepatocarcinoma resistance QTL 13 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 4:1...33,538,816
|
|
Q |
Hcar14 |
Hepatocarcinoma resistance QTL 14 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr18:57,825,243...85,493,247
|
|
Q |
Hcar2 |
Hepatocarcinoma resistance QTL 2 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 4:84,349,032...129,349,032
|
|
Q |
Hcar3 |
Hepatocarcinoma resistance QTL 3 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 8:62,982,864...107,982,864
|
|
Q |
Hcar9 |
Hepatocarcinoma resistance QTL 9 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 4:106,848,959...168,870,974
|
|
Q |
Hcas1 |
Hepatocarcinoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 7:93,302,009...131,686,183
|
|
Q |
Hcas2 |
Hepatocarcinoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 1:7,746,118...52,746,118
|
|
Q |
Hcas3 |
Hepatocarcinoma susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 1:153,679,879...232,414,077
|
|
Q |
Hcas4 |
Hepatocarcinoma susceptibility QTL 4 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr16:4,234,212...53,708,481
|
|
Q |
Hcas5 |
Hepatocarcinoma susceptibility QTL 5 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 1:185,857,683...270,518,180
|
|
Q |
Hcas6 |
Hepatocarcinoma susceptibility QTL 6 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr14:39,411,170...87,582,095
|
|
Q |
Hcas7 |
Hepatocarcinoma susceptibility QTL 7 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr15:2,315,759...53,331,089
|
|
Q |
Lnnr1 |
Liver neoplastic nodule remodeling QTL 1 |
|
IDA |
|
RGD |
PMID:12672032 |
RGD:629574 |
NCBI chr 7:36,178,764...81,178,764
|
|
Q |
Lnnr2 |
Liver neoplastic nodule remodeling QTL 2 |
|
IDA |
|
RGD |
PMID:12672032 |
RGD:629574 |
NCBI chr 1:243,953,669...270,518,180
|
|
Q |
Lnnr3 |
Liver neoplastic nodule remodeling QTL 3 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 2:1...42,977,529
|
|
Q |
Lnnr4 |
Liver neoplastic nodule remodeling QTL 4 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:1...34,785,618
|
|
Q |
Lnnr5 |
Liver neoplastic nodule remodeling QTL 5 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:62,424,592...88,113,509
|
|
Q |
Lnnr6 |
Liver neoplastic nodule remodeling QTL 6 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:65,613,454...109,350,286
|
|
|
Q |
Hcar15 |
Hepatocarcinoma resistance QTL 15 |
|
IDA |
|
RGD |
PMID:15771619 |
RGD:1358145 |
NCBI chr 1:162,548,015...270,518,180
|
|
|
Q |
Tcas10 |
Tongue tumor susceptibility QTL 10 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr10:31,796,281...76,796,281
|
|
Q |
Tcas11 |
Tongue tumor susceptibility QTL 11 |
|
IDA |
|
RGD |
PMID:16527513 |
RGD:1578522 |
NCBI chr 5:51,657,967...166,600,247
|
|
Q |
Tcas2 |
Tongue tumor susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 1:201,915,593...208,479,939
|
|
Q |
Tcas3 |
Tongue tumor susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 4:11,706,604...92,690,519
|
|
Q |
Tcas4 |
Tongue tumor susceptibility QTL 4 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr14:17,906,726...54,251,504
|
|
Q |
Tcas5 |
Tongue tumor susceptibility QTL 5 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
|
|
Q |
Tcas6 |
Tongue tumor susceptibility QTL 6 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 1:102,359,314...153,680,016
|
|
Q |
Tcas7 |
Tongue tumor susceptibility QTL 7 |
|
IDA |
|
RGD |
PMID:15876484 |
RGD:1358147 |
NCBI chr19:41,722,546...74,246,245
|
|
Q |
Tcas8 |
Tongue tumor susceptibility QTL 8 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 5:15,707,451...60,707,451
|
|
Q |
Tcas9 |
Tongue tumor susceptibility QTL 9 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
|
|
|
Q |
Mamtr1 |
Mammary tumor resistance QTL 1 |
|
IDA |
|
RGD |
PMID:12844486 |
RGD:631852 |
NCBI chr 5:17,576,633...62,576,633
|
|
Q |
Mamtr2 |
Mammary tumor resistance QTL 2 |
|
IDA |
|
RGD |
PMID:14522903 |
RGD:724790 |
NCBI chr 2:9,623,581...54,623,581
|
|
Q |
Mamtr3 |
Mammary tumor resistance QTL 3 |
|
IDA |
|
RGD |
PMID:14522903 |
RGD:724790 |
|
|
Q |
Mamtr4 |
Mammary tumor resistance QTL 4 |
|
IDA |
|
RGD |
PMID:14522903 |
RGD:724790 |
NCBI chr 2:18,227,137...63,227,137
|
|
Q |
Mamtr5 |
Mammary tumor resistance QTL 5 |
|
IDA |
65mg/kg body mass |
RGD |
PMID:17230524 |
RGD:1599390 |
NCBI chr 5:23,671,493...68,671,493
|
|
Q |
Mamtr6 |
Mammary tumor resistance QTL 6 |
|
IDA |
65mg/kg body mass |
RGD |
PMID:17230524 |
RGD:1599390 |
NCBI chr18:19,553,532...85,493,247
|
|
Q |
Mamtr7 |
Mammary tumor resistance QTL 7 |
|
IDA |
65mg/kg body mass |
RGD |
PMID:19052818 |
RGD:2302423 |
|
|
Q |
Mamtr8 |
Mammary tumor resistance QTL 8 |
|
IDA |
65mg/ml body mass |
RGD |
PMID:19052818 |
RGD:2302423 |
NCBI chr18:31,610,505...85,493,247
|
|
Q |
Mcs1 |
Mammary carcinoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:8168109 |
RGD:61080 |
NCBI chr 2:9,623,581...25,054,526
|
|
Q |
Mcs12 |
Mammary carcinoma susceptibility QTL 12 |
|
IDA |
|
RGD |
PMID:16266982 |
RGD:1559294 |
NCBI chr 5:58,973,449...60,051,321
|
|
Q |
Mcs13 |
Mammary carcinoma susceptibility QTL 13 |
|
IDA |
|
RGD |
PMID:16266982 |
RGD:1559294 |
NCBI chr 5:63,190,890...69,927,503
|
|
Q |
Mcs14 |
Mammary carcinoma susceptibility QTL 14 |
|
IDA |
|
RGD |
PMID:16266982 |
RGD:1559294 |
NCBI chr 5:76,369,776...80,813,390
|
|
Q |
Mcs15 |
Mammary carcinoma susceptibility QTL 15 |
|
IDA |
|
RGD |
PMID:16568087 |
RGD:1581951 |
NCBI chr10:72,724,423...107,713,808
|
|
Q |
Mcs16 |
Mammary carcinoma susceptibility QTL 16 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 1:1...26,564,886
|
|
Q |
Mcs17 |
Mammary carcinoma susceptibility QTL 17 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 1:207,099,883...252,099,883
|
|
Q |
Mcs18 |
Mammary carcinoma susceptibility QTL 18 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 2:9,623,581...44,538,110
|
|
Q |
Mcs19 |
Mammary carcinoma susceptibility QTL 19 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 5:82,032,155...127,032,155
|
|
Q |
Mcs2 |
Mammary carcinoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 7:20,920,494...37,412,865
|
|
Q |
Mcs20 |
Mammary carcinoma susceptibility QTL 20 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 9:21,031,430...49,025,574
|
|
Q |
Mcs21 |
Mammary carcinoma susceptibility QTL 21 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr10:29,377,046...52,699,134
|
|
Q |
Mcs22 |
Mammary carcinoma susceptibility QTL 22 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
|
|
Q |
Mcs23 |
Mammary carcinoma susceptibility QTL 23 |
|
IDA |
|
RGD |
PMID:17404222 |
RGD:1601189 |
|
|
Q |
Mcs24 |
Mammary carcinoma susceptibility QTL 24 |
|
IDA |
|
RGD |
PMID:17404222 |
RGD:1601189 |
NCBI chr 5:69,835,120...114,835,120
|
|
Q |
Mcs25 |
Mammary carcinoma susceptibility QTL 25 |
|
IDA |
65mg/kg body weight |
RGD |
PMID:20737482 |
RGD:4143380 |
NCBI chr 6:10,894,415...110,548,006
|
|
Q |
Mcs26 |
Mammary carcinoma susceptibility QTL 26 |
|
IDA |
65mg/kg body weight |
RGD |
PMID:20737482 |
RGD:4143380 |
NCBI chr 6:112,483,610...147,156,653
|
|
Q |
Mcs27 |
Mammary carcinoma susceptibility QTL 27 |
|
IDA |
65mg/kg body weight |
RGD |
PMID:20737482 |
RGD:4143380 |
NCBI chr13:45,990,077...50,392,939
|
|
Q |
Mcs28 |
Mammary carcinoma susceptibility QTL 28 |
|
IDA |
|
RGD |
PMID:21205740 |
RGD:5684388 |
|
|
Q |
Mcs29 |
Mammary carcinoma susceptibility QTL 29 |
|
IDA |
|
RGD |
PMID:21205740 |
RGD:5684388 |
NCBI chr 5:38,004,331...83,004,331
|
|
Q |
Mcs3 |
Mammary carcinoma susceptibility QTL 3 |
|
IDA |
65mg/kg body weight |
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 1:111,404,407...142,582,336
|
|
Q |
Mcs4 |
Mammary carcinoma susceptibility QTL 4 |
|
IDA |
65mg/kg body weight |
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 8:44,475,043...89,475,043
|
|
Q |
Mcs5 |
Mammary carcinoma susceptibility QTL 5 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 5:60,601,597...137,492,949
|
|
Q |
Mcs6 |
Mammary carcinoma susceptibility QTL 6 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 7:28,624,575...65,788,017
|
|
Q |
Mcs7 |
Mammary carcinoma susceptibility QTL 7 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr10:72,724,423...107,713,808
|
|
Q |
Mcs8 |
Mammary carcinoma susceptibility QTL 8 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr14:3,957,878...24,886,169
|
|
Q |
Mcsm1 |
Mammary carcinoma susceptibility modifier QTL 1 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 6:64,367,996...109,367,996
|
|
|
Q |
Iresp1 |
Immunoglobin response QTL1 |
|
IDA |
|
RGD |
PMID:10898507 |
RGD:619646 |
NCBI chr20:9,039,719...13,461,775
|
|
Q |
Iresp2 |
Immunoglobin response QTL2 |
|
IDA |
|
RGD |
PMID:10898507 |
RGD:619646 |
NCBI chr10:22,918,268...36,400,810
|
|
Q |
Iresp3 |
Immunoglobin response QTL3 |
|
IDA |
|
RGD |
PMID:10898507 |
RGD:619646 |
NCBI chr 9:2,745,799...5,857,951
|
|
|
Q |
Hcar4 |
Hepatocarcinoma resistance QTL 4 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
NCBI chr 1:202,851,915...223,964,440
|
|
Q |
Hcar5 |
Hepatocarcinoma resistance QTL 5 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
NCBI chr 1:223,964,326...236,074,012
|
|
Q |
Hcar6 |
Hepatocarcinoma resistance QTL 6 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
|
|
Q |
Hcar7 |
Hepatocarcinoma resistance QTL 7 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
NCBI chr 4:61,041,057...94,638,356
|
|
Q |
Hcar8 |
Hepatocarcinoma resistance QTL 8 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
NCBI chr 4:124,700,988...169,700,988
|
|
|
Q |
Tcas1 |
Tongue tumor susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:9563479 |
RGD:61091 |
NCBI chr19:19,220,689...64,220,689
|
|
Q |
Tcat1 |
Tongue tumor resistance QTL 1 |
|
IDA |
|
RGD |
PMID:9563479 |
RGD:61091 |
NCBI chr 1:108,680,016...153,680,016
|
|
|
Q |
Gcr1 |
Gastric cancer resistance QTL 1 |
|
IDA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr 4:103,834,277...148,834,277
|
|
Q |
Gcr2 |
Gastric cancer resistance QTL 2 |
|
IDA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr 3:29,056,275...47,904,329
|
|
Q |
Gcr3 |
Gastric cancer resistance QTL 3 |
|
IDA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr16:17,730,818...72,536,785
|
|
Q |
Gcs1 |
Gastric cancer susceptibility QTL1 |
|
IDA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr15:82,714,037...106,778,197
|
|
|
Q |
Tls1 |
T-lymphoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:10360666 |
RGD:619600 |
|
|
Q |
Tls2 |
T-lymphoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:10360666 |
RGD:619600 |
NCBI chr 7:82,111,382...132,099,989
|
|
Q |
Tls3 |
T-lymphoma susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:10360666 |
RGD:619600 |
NCBI chr10:27,587,226...96,099,902
|
|
|
Q |
Mcs30 |
Mammary carcinoma susceptibility QTL 30 |
|
IDA |
|
RGD |
PMID:24023717 |
RGD:7327193 |
NCBI chr12:5,633,306...50,633,306
|
|
|
Q |
Hcar1 |
Hepatocarcinoma resistance QTL 1 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr10:6,661,118...35,509,383
|
|
Q |
Hcar10 |
Hepatocarcinoma resistance QTL 10 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 8:49,610,204...68,373,388
|
|
Q |
Hcar11 |
Hepatocarcinoma resistance QTL 11 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 6:46,050,607...116,278,722
|
|
Q |
Hcar12 |
Hepatocarcinoma resistance QTL 12 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 3:49,872,657...138,829,559
|
|
Q |
Hcar13 |
Hepatocarcinoma resistance QTL 13 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 4:1...33,538,816
|
|
Q |
Hcar14 |
Hepatocarcinoma resistance QTL 14 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr18:57,825,243...85,493,247
|
|
Q |
Hcar2 |
Hepatocarcinoma resistance QTL 2 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 4:84,349,032...129,349,032
|
|
Q |
Hcar3 |
Hepatocarcinoma resistance QTL 3 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 8:62,982,864...107,982,864
|
|
Q |
Hcar9 |
Hepatocarcinoma resistance QTL 9 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 4:106,848,959...168,870,974
|
|
Q |
Hcas1 |
Hepatocarcinoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 7:93,302,009...131,686,183
|
|
Q |
Hcas2 |
Hepatocarcinoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 1:7,746,118...52,746,118
|
|
Q |
Hcas3 |
Hepatocarcinoma susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 1:153,679,879...232,414,077
|
|
Q |
Hcas4 |
Hepatocarcinoma susceptibility QTL 4 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr16:4,234,212...53,708,481
|
|
Q |
Hcas5 |
Hepatocarcinoma susceptibility QTL 5 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 1:185,857,683...270,518,180
|
|
Q |
Hcas6 |
Hepatocarcinoma susceptibility QTL 6 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr14:39,411,170...87,582,095
|
|
Q |
Hcas7 |
Hepatocarcinoma susceptibility QTL 7 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr15:2,315,759...53,331,089
|
|
Q |
Hcas8 |
Hepatocarcinoma susceptibility QTL 8 |
|
IDA |
|
RGD |
PMID:17079458 |
RGD:1599590 |
NCBI chr16:16,278,184...27,244,292
|
|
Q |
Lnnr1 |
Liver neoplastic nodule remodeling QTL 1 |
|
IDA |
|
RGD |
PMID:12672032 |
RGD:629574 |
NCBI chr 7:36,178,764...81,178,764
|
|
Q |
Lnnr2 |
Liver neoplastic nodule remodeling QTL 2 |
|
IDA |
|
RGD |
PMID:12672032 |
RGD:629574 |
NCBI chr 1:243,953,669...270,518,180
|
|
Q |
Lnnr3 |
Liver neoplastic nodule remodeling QTL 3 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 2:1...42,977,529
|
|
Q |
Lnnr4 |
Liver neoplastic nodule remodeling QTL 4 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:1...34,785,618
|
|
Q |
Lnnr5 |
Liver neoplastic nodule remodeling QTL 5 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:62,424,592...88,113,509
|
|
Q |
Lnnr6 |
Liver neoplastic nodule remodeling QTL 6 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:65,613,454...109,350,286
|
|
|
Q |
Aia10 |
Adjuvant induced arthritis QTL 10 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr15:82,194,914...108,192,169
|
|
Q |
Aia11 |
Adjuvant induced arthritis QTL 11 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr17:26,522,051...71,522,051
|
|
Q |
Aia12 |
Adjuvant induced arthritis QTL 12 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
|
|
Q |
Aia13 |
Adjuvant induced arthritis QTL 13 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 2:78,269,809...123,269,809
|
|
Q |
Aia14 |
Adjuvant induced arthritis QTL 14 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
|
|
Q |
Aia15 |
Adjuvant induced arthritis QTL 15 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 7:49,682,832...63,890,004
|
|
Q |
Aia16 |
Adjuvant induced arthritis QTL 16 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 7:71,103,011...106,126,789
|
|
Q |
Aia17 |
Adjuvant induced arthritis QTL 17 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 7:83,626,689...128,626,689
|
|
Q |
Aia18 |
Adjuvant induced arthritis QTL 18 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 8:16,994,642...61,994,642
|
|
Q |
Aia19 |
Adjuvant induced arthritis QTL 19 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr10:67,476,608...73,695,498
|
|
Q |
Aia20 |
Adjuvant induced arthritis QTL 20 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr10:73,695,339...83,061,459
|
|
Q |
Aia21 |
Adjuvant induced arthritis QTL 21 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr13:12,384,320...57,384,320
|
|
Q |
Aia22 |
Adjuvant induced arthritis QTL 22 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr13:1...34,785,618
|
|
Q |
Aia23 |
Adjuvant induced arthritis QTL 23 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr13:12,285,517...34,884,386
|
|
Q |
Aia24 |
Adjuvant induced arthritis QTL 24 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr15:59,257,087...104,257,087
|
|
Q |
Aia25 |
Adjuvant induced arthritis QTL 25 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr17:10,604,694...55,604,694
|
|
Q |
Aia26 |
Adjuvant induced arthritis QTL 26 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
|
|
Q |
Aia27 |
Adjuvant induced arthritis QTL 27 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr20:1...26,925,056
|
|
Q |
Aia6 |
Adjuvant induced arthritis QTL 6 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr10:67,476,608...73,695,498
|
|
Q |
Aia7 |
Adjuvant induced arthritis QTL 7 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr10:73,695,339...83,061,459
|
|
Q |
Aia8 |
Adjuvant induced arthritis QTL 8 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr13:12,384,320...57,384,320
|
|
Q |
Aia9 |
Adjuvant induced arthritis QTL 9 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr13:12,285,517...34,884,386
|
|
Q |
Ginf1 |
Gastrointestinal inflammation QTL 1 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 8:4,705,810...49,705,810
|
|
Q |
Ginf2 |
Gastrointestinal inflammation QTL 2 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 8:4,705,810...49,705,810
|
|
Q |
Ginf3 |
Gastrointestinal inflammation QTL 3 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr17:49,920,154...86,533,673
|
|
Q |
Livw3 |
Liver weight QTL 3 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 8:4,705,810...49,705,810
|
|
Q |
Wbc3 |
White blood cell count QTL 3 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 5:105,999,803...150,999,803
|
|
Q |
Wbc4 |
White blood cell count QTL 4 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 7:1...35,342,956
|
|
Q |
Wbc5 |
White blood cell count QTL 5 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 8:8,736,635...53,736,635
|
|
|
Q |
Apr1 |
Acute phase response QTL 1 |
|
IDA |
|
RGD |
PMID:11817600 |
RGD:629561 |
NCBI chr12:24,805,022...52,308,831
|
|
Q |
Apr2 |
Acute phase response QTL 2 |
|
IDA |
|
RGD |
PMID:11817600 |
RGD:629561 |
|
|
Q |
Apr3 |
Acute phase response QTL 3 |
|
IDA |
|
RGD |
PMID:11817600 |
RGD:629561 |
NCBI chr10:15,776,754...60,776,754
|
|
Q |
Apr4 |
Acute phase response QTL 4 |
|
IDA |
|
RGD |
PMID:11817600 |
RGD:629561 |
|
|
Q |
Apr5 |
Acute phase response QTL 5 |
|
IDA |
|
RGD |
PMID:11817600 |
RGD:629561 |
|
|
Q |
Apr6 |
Acute phase response QTL 6 |
|
IDA |
|
RGD |
PMID:11817600 |
RGD:629561 |
NCBI chr14:1...41,415,516
|
|
Q |
Oia7 |
Oil induced arthritis QTL 7 |
|
IDA |
|
RGD |
PMID:12915467 |
RGD:730281 |
NCBI chr 4:156,050,654...157,232,313
|
|
Q |
Pia1 |
Pristane induced arthritis QTL 1 |
|
IDA |
|
RGD |
PMID:9843218 |
RGD:61089 |
|
|
Q |
Pia10 |
Pristane induced arthritis QTL 10 |
|
IDA |
|
RGD |
PMID:12209529 |
RGD:629569 |
NCBI chr10:23,444,813...104,060,283
|
|
Q |
Pia11 |
Pristane induced arthritis QTL 11 |
|
IDA |
|
RGD |
PMID:12111642 |
RGD:631225 |
NCBI chr 1:136,830,018...181,830,018
|
|
Q |
Pia12 |
Pristane induced arthritis QTL 12 |
|
IDA |
|
RGD |
PMID:12111642 |
RGD:631225 |
NCBI chr12:20,259,417...23,672,083
|
|
Q |
Pia13 |
Pristane induced arthritis QTL 13 |
|
IDA |
|
RGD |
PMID:12111642 |
RGD:631225 |
NCBI chr14:40,793,460...98,037,301
|
|
Q |
Pia14 |
Pristane induced arthritis QTL 14 |
|
IDA |
|
RGD |
PMID:12111642 |
RGD:631225 |
NCBI chr16:55,711,087...83,402,471
|
|
Q |
Pia15 |
Pristane induced arthritis QTL 15 |
|
IDA |
|
RGD |
PMID:12817024 |
RGD:631850 |
NCBI chr10:1...24,158,324
|
|
Q |
Pia16 |
Pristane induced arthritis QTL 16 |
|
IDA |
|
RGD |
PMID:12817024 |
RGD:631850 |
NCBI chr 6:45,790,088...104,200,226
|
|
Q |
Pia17 |
Pristane induced arthritis QTL 17 |
|
IDA |
|
RGD |
PMID:12817024 |
RGD:631850 |
NCBI chr 7:73,829,340...130,221,005
|
|
Q |
Pia18 |
Pristane induced arthritis QTL 18 |
|
IDA |
|
RGD |
PMID:12817024 |
RGD:631850 |
NCBI chr 8:75,311,938...82,925,521
|
|
Q |
Pia19 |
Pristane induced arthritis QTL 19 |
|
IDA |
|
RGD |
PMID:12817024 |
RGD:631850 |
NCBI chr18:73,997,140...79,532,029
|
|
Q |
Pia2 |
Pristane induced arthritis QTL 2 |
|
IDA |
|
RGD |
PMID:9843218 |
RGD:61089 |
NCBI chr 4:21,333,343...62,278,020
|
|
Q |
Pia20 |
Pristane induced arthritis QTL 20 |
|
IDA |
|
RGD |
PMID:14624754 |
RGD:730280 |
NCBI chr14:9,088,978...39,057,237
|
|
Q |
Pia21 |
Pristane induced arthritis QTL 21 |
|
IDA |
|
RGD |
PMID:12817024 |
RGD:631850 |
NCBI chr20:3,621,656...4,606,812
|
|
Q |
Pia22 |
Pristane induced arthritis QTL 22 |
|
IDA |
|
RGD |
PMID:12817024 |
RGD:631850 |
NCBI chr12:1...44,465,750
|
|
Q |
Pia23 |
Pristane induced arthritis QTL 23 |
|
IDA |
|
RGD |
PMID:12817024 |
RGD:631850 |
NCBI chr 4:131,730,738...167,139,601
|
|
Q |
Pia24 |
Pristane induced arthritis QTL 24 |
|
IDA |
|
RGD |
PMID:14611807 |
RGD:728382 |
NCBI chr 6:112,636,280...140,994,061
|
|
Q |
Pia25 |
Pristane induced arthritis QTL 25 |
|
IDA |
|
RGD |
PMID:15944295 |
RGD:1359065 |
NCBI chr10:96,120,911...104,060,283
|
|
Q |
Pia26 |
Pristane induced arthritis QTL 26 |
|
IDA |
|
RGD |
PMID:15944295 |
RGD:1359065 |
NCBI chr10:31,224,026...75,632,053
|
|
Q |
Pia27 |
Pristane induced arthritis QTL 27 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
|
|
Q |
Pia28 |
Pristane induced arthritis QTL 28 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
|
|
Q |
Pia29 |
Pristane induced arthritis QTL 29 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr16:28,468,701...73,468,701
|
|
Q |
Pia3 |
Pristane induced arthritis QTL 3 |
|
IDA |
|
RGD |
PMID:9843218 |
RGD:61089 |
NCBI chr 6:94,968,928...137,848,904
|
|
Q |
Pia30 |
Pristane induced arthritis QTL 30 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
|
|
Q |
Pia31 |
Pristane induced arthritis QTL 31 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr 1:12,820,494...57,820,494
|
|
Q |
Pia32 |
Pristane induced arthritis QTL 32 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr 4:107,346,299...152,346,299
|
|
Q |
Pia33 |
Pristane induced arthritis QTL 33 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
|
|
Q |
Pia34 |
Pristane induced arthritis QTL 34 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr X:96,916,163...141,916,163
|
|
Q |
Pia35 |
Pristane induced arthritis QTL 35 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr 1:226,175,591...270,518,180
|
|
Q |
Pia36 |
Pristane induced arthritis QTL 36 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
|
|
Q |
Pia37 |
Pristane induced arthritis QTL 37 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
|
|
Q |
Pia38 |
Pristane induced arthritis QTL 38 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
|
|
Q |
Pia39 |
Pristane induced arthritis QTL 39 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr14:8,621,398...53,621,398
|
|
Q |
Pia4 |
Pristane induced arthritis QTL 4 |
|
IDA |
|
RGD |
PMID:9843218 |
RGD:61089 |
NCBI chr12:13,635,523...30,827,399
|
|
Q |
Pia40 |
Pristane induced arthritis QTL 40 |
|
IDA |
|
RGD |
PMID:19180494 |
RGD:2306838 |
NCBI chr20:1,527,959...5,304,575
|
|
Q |
Pia41 |
Pristane induced arthritis QTL 41 |
|
IDA |
|
RGD |
PMID:20072140 |
RGD:6892695 |
NCBI chr 1:188,241,285...233,241,285
|
|
Q |
Pia42 |
Pristane induced arthritis QTL 42 |
|
IDA |
|
RGD |
PMID:17329308 |
RGD:1600250 |
NCBI chr12:19,610,870...42,828,880
|
|
Q |
Pia5 |
Pristane induced arthritis QTL 5 |
|
IDA |
|
RGD |
PMID:9843218 |
RGD:61089 |
NCBI chr 4:62,277,855...128,289,560
|
|
Q |
Pia6 |
Pristane induced arthritis QTL 6 |
|
IDA |
|
RGD |
PMID:9843218 |
RGD:61089 |
NCBI chr14:18,631,345...42,337,007
|
|
Q |
Pia7 |
Pristane induced arthritis QTL 7 |
|
IDA |
|
RGD |
PMID:11090241 |
RGD:629570 |
NCBI chr 4:131,730,738...167,139,601
|
|
Q |
Pia8 |
Pristane induced arthritis QTL 8 |
|
IDA |
|
RGD |
PMID:11090241 |
RGD:629570 |
NCBI chr 1:1...65,833,076
|
|
Q |
Pia9 |
Pristane induced arthritis QTL 9 |
|
IDA |
|
RGD |
PMID:12571866 |
RGD:629560 |
NCBI chr 4:80,694,870...125,694,870
|
|
|
Q |
Cia1 |
Collagen induced arthritis QTL 1 |
|
IDA |
|
RGD |
PMID:8782824 |
RGD:61062 |
NCBI chr20:3,621,656...14,101,050
|
|
Q |
Cia10 |
Collagen induced arthritis QTL 10 |
|
IDA |
|
RGD |
PMID:9870869 |
RGD:61063 |
NCBI chr 2:179,946,951...224,946,951
|
|
Q |
Cia11 |
Collagen induced arthritis QTL 11 |
|
IDA |
|
RGD |
PMID:10857786 |
RGD:61066 |
NCBI chr 3:30,356,773...98,535,386
|
|
Q |
Cia12 |
Collagen induced arthritis QTL 12 |
|
IDA |
|
RGD |
PMID:10857786 |
RGD:61066 |
NCBI chr12:13,635,523...35,682,913
|
|
Q |
Cia13 |
Collagen induced arthritis QTL 13 |
|
IDA |
|
RGD |
PMID:11001927 |
RGD:61067 |
NCBI chr 4:132,642,577...167,139,601
|
|
Q |
Cia14 |
Collagen induced arthritis QTL 14 |
|
IDA |
|
RGD |
PMID:10857786 |
RGD:61066 |
NCBI chr19:10,827,970...43,544,039
|
|
Q |
Cia15 |
Collagen induced arthritis QTL 15 |
|
IDA |
|
RGD |
PMID:11001927 |
RGD:61067 |
NCBI chr 9:5,109,826...42,921,101
|
|
Q |
Cia16 |
Collagen induced arthritis QTL 16 |
|
IDA |
|
RGD |
PMID:11001927 |
RGD:61067 |
NCBI chr10:6,357,896...96,121,100
|
|
Q |
Cia17 |
Collagen induced arthritis QTL 17 |
|
IDA |
|
RGD |
PMID:11001927 |
RGD:61067 |
NCBI chr18:31,359,408...70,263,868
|
|
Q |
Cia18 |
Collagen induced arthritis QTL 18 |
|
IDA |
|
RGD |
PMID:11001927 |
RGD:61067 |
NCBI chr X:14,843,113...120,568,734
|
|
Q |
Cia19 |
Collagen induced arthritis QTL 19 |
|
IDA |
|
RGD |
PMID:11001927 |
RGD:61067 |
NCBI chr X:65,612,192...120,568,734
|
|
Q |
Cia2 |
Collagen induced arthritis QTL 2 |
|
IDA |
|
RGD |
PMID:8782824 |
RGD:61062 |
NCBI chr 1:78,430,754...91,209,302
|
|
Q |
Cia20 |
Collagen induced arthritis QTL 20 |
|
IDA |
|
RGD |
PMID:11003387 |
RGD:631168 |
NCBI chr10:23,444,813...104,060,283
|
|
Q |
Cia21 |
Collagen induced arthritis QTL 21 |
|
IDA |
|
RGD |
PMID:11003387 |
RGD:631168 |
NCBI chr10:14,487,011...104,060,283
|
|
Q |
Cia22 |
Collagen induced arthritis QTL 22 |
|
IDA |
|
RGD |
PMID:11003387 |
RGD:631168 |
NCBI chr10:40,035,094...104,060,283
|
|
Q |
Cia23 |
Collagen induced arthritis QTL 23 |
|
IDA |
|
RGD |
PMID:11003387 |
RGD:631168 |
NCBI chr10:40,035,094...104,060,283
|
|
Q |
Cia24 |
Collagen induced arthritis QTL 24 |
|
IDA |
|
RGD |
PMID:10857786 |
RGD:61066 |
NCBI chr 4:146,565,735...175,236,377
|
|
Q |
Cia25 |
Collagen induced arthritis QTL 25 |
|
IDA |
|
RGD |
PMID:15334486 |
RGD:1285224 |
NCBI chr12:19,610,889...35,682,913
|
|
Q |
Cia26 |
Collagen induced arthritis QTL 26 |
|
IDA |
|
RGD |
PMID:15334486 |
RGD:1285224 |
NCBI chr18:54,709,769...83,828,827
|
|
Q |
Cia27 |
Collagen induced arthritis QTL 27 |
|
IDA |
|
RGD |
PMID:9870869 |
RGD:61063 |
NCBI chr10:76,452,683...107,211,142
|
|
Q |
Cia28 |
Collagen induced arthritis QTL 28 |
|
IDA |
|
RGD |
PMID:15944295 |
RGD:1359065 |
NCBI chr10:96,120,911...104,060,283
|
|
Q |
Cia29 |
Collagen induced arthritis QTL 29 |
|
IDA |
|
RGD |
PMID:15944295 |
RGD:1359065 |
NCBI chr10:33,973,921...78,973,921
|
|
Q |
Cia3 |
Collagen induced arthritis QTL 3 |
|
IDA |
|
RGD |
PMID:8782824 |
RGD:61062 |
NCBI chr 4:103,194,656...148,194,656
|
|
Q |
Cia4 |
Collagen induced arthritis QTL 4 |
|
IDA |
|
RGD |
PMID:8782824 |
RGD:61062 |
NCBI chr 7:58,113,224...62,004,598
|
|
Q |
Cia5 |
Collagen induced arthritis QTL 5 |
|
IDA |
|
RGD |
PMID:8782824 |
RGD:61062 |
NCBI chr10:91,228,102...104,060,283
|
|
Q |
Cia6 |
Collagen induced arthritis QTL 6 |
|
IDA |
|
RGD |
PMID:11001927 |
RGD:61067 |
NCBI chr 8:82,460,758...122,812,818
|
|
Q |
Cia7 |
Collagen induced arthritis QTL 7 |
|
IDA |
|
RGD |
PMID:11001927 |
RGD:61067 |
NCBI chr 2:59,324,377...141,596,857
|
|
Q |
Cia8 |
Collagen induced arthritis QTL 8 |
|
IDA |
|
RGD |
PMID:10398805 |
RGD:61069 |
|
|
Q |
Cia9 |
Collagen induced arthritis QTL 9 |
|
IDA |
|
RGD |
PMID:9870869 |
RGD:61063 |
|
|
Q |
Ciaa1 |
CIA Autoantibody QTL 1 |
|
IDA |
|
RGD |
PMID:11001927 |
RGD:61067 |
NCBI chr20:2,646,395...4,597,031
|
|
Q |
Ciaa2 |
CIA Autoantibody QTL 2 |
|
IDA |
|
RGD |
PMID:10857786 |
RGD:61066 |
NCBI chr10:63,221,094...107,211,142
|
|
Q |
Ciaa3 |
CIA Autoantibody QTL 3 |
|
IDA |
|
RGD |
PMID:10857786 |
RGD:61066 |
NCBI chr 9:7,954,720...22,071,169
|
|
Q |
Ciaa4 |
CIA Autoantibody QTL 4 |
|
IDA |
|
RGD |
PMID:11001927 |
RGD:61067 |
NCBI chr 4:126,395,976...167,139,601
|
|
Q |
Ciaa5 |
CIA Autoantibody QTL 5 |
|
IDA |
|
RGD |
PMID:11001927 |
RGD:61067 |
NCBI chr 5:94,858,972...143,070,159
|
|